Inhibition of dynein but not kinesin induces aberrant focal accumulation of neurofilaments within axonal neurites

Brain Research

Volumn 1164, Issue 1, 2007, Pages 125-131

  Motil, Jennifer ^a   Dubey, Maya ^a   Chan, Walter K H ^a   Shea, Thomas B ^a  

^a University of Massachusetts Lowell   (United States)

Author keywords

ALS; Axonal transport; Dynein; Kinesin; Neurofilament; Spheroid

Indexed keywords

DYNEIN ADENOSINE TRIPHOSPHATASE; KINESIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; MOTOR NEURON DISEASE; MOUSE; NERVE FIBER; NEURITE; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; AXONAL TRANSPORT; AXONS; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM; DYNEIN ATPASE; KINESIN; MICE; MICROFILAMENTS; MICROTUBULE-ASSOCIATED PROTEINS; NEUROFILAMENT PROTEINS;

EID: 34547571144     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.09.108     Document Type: Article

References (68)

1. Ackerley S., Grierson A.J., Banner S., Perkinton M.S., Brownlees J., Byers H.L., Ward M., Thornhill P., Hussain K., Waby J.S., Anderton B.H., Cooper J.D., Dingwall C., Leigh PN., Shaw C.E., and Miller C.C. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 26 (2004) 354-364
2. Ahmad-Annuar A., Shah P., Hafezparast M., Hummerich H., Witherden A.S., Morrison K.E., Shaw P.J., Kirby J., Warner T.T., Crosby A., Proukakis C., Wilkinson P., Orrell R.W., Bradley L., Martin J.E., and Fisher E.M. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 4 (2003) 150-157
3. Ahmad F.J., Echeverri C.J., Vallee R.B., and Baas P.W. Cytoplasmic dynein and dynactin are required for the transport of microtubules into the axon. J. Cell Biol. 140 (1998) 391-401
4. Ahmad F.J., Hughey J., Wittmann T., Hyman A., Greaser M., and Baas P.W. Motor proteins regulate force interactions between microtubules and microfilaments in the axon. Nat. Cell Biol. 2 (2000) 276-280
5. Allan V.J., Thompson H.M., and McNiven M.A. Motoring around the Golgi. Nat. Cell Biol. 4 (2002) E236-E242
6. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 6 (2006) 37-46
7. Anderton B.H., Breinburg D., Downes M.J., Green P.J., Tomlinson B.E., Ulrich J., Wood J.N., and Kahn J. Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature 298 (1982) 84-86
8. Beaulieu J.M., and Julien J.P. Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins. J. Neurochem. 85 (2003) 248-256
9. Brettschneider J., Petzold A., Sussmuth S.D., Ludolph A.C., and Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66 (2006) 826-852
10. Brown A. Continguous phosphorylated and non-phosphorylated domains along axonal neurofilaments. J. Cell Sci. 111 (1998) 455-467
11. Bruijn L.I., and Cudkowicz M. Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies. Expert Rev. Neurotherapeutics 6 (2006) 417-428
12. Burkhardt J.K. The role of microtubule-based motor proteins in maintaining the structure and function of the Golgi complex. Biochim. Biophys. Acta 1404 (1988) 113-126
13. Chan W.K.-C., Dickerson A., Otriz D., Pimenta A., Moran C., Malik K., Motil J., Snyder S., Pant H.C., and Shea T.B. Mitogen activated protein kinase regulates neurofilament axonal transport. J. Cell Sci. 117 (2004) 4629-4642
14. Chan W.K.-H., Yabe J.T., Pimenta A.F., Ortiz D., and Shea T.B. Neurofilaments can undergo transport and cytoskeletal incorporation in a discontinuous manner. Cell Motil. Cytoskel. 62 (2005) 166-179
15. Chou S.M., Wang H.S., and Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J. Chem. Neuroanat. 10 (1996) 249-258
16. Chou S.M., Wang H.S., and Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J. Neurol. Sci. 139 (1996) 16-26
17. Collard J.F., Cote F., and Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375 (1995) 61-64
18. Corcoran L.J., Mitchison T.J., and Liu Q. A novel action of histone deacetylase inhibitors in a protein aggresome disease model. Curr. Biol. 14 (2004) 488-492
19. DeWaegh S.M., Lee V.M., and Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68 (1992) 451-463
20. Gonatas N.K., Stieber A., Mourelatos Z., Chen Y., Gonatas J.O., Appel S.H., Hays A.P., Hickey W.F., and Hauw J.J. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am. J. Pathol. 140 (1992) 731-737
21. Hafezparast M., Klocke R., Marquardt C., Ahmad-Annuar A., Bowen A., Lalli S., Witherden G., Hummerich A.S., Nicholson H., Morgan S., Oozageer P.J., Priestley R., Averill J.V., King S., Ball V.R., Peters S., Toda J., Yamamoto T., Hiraoka A., Augustin Y., Korthaus M., Wattler D., Wabnitz S., Dickneite P., Lampel C., Boehme S., Peraus F., Popp G., Rudelius A., Schlegel M., Fuchs J., Hrabe de Angelis H., Schiavo M., Shima G., Russ D.T., Stumm A.P., Martin G., and Fisher J.E. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
22. Helfand B.T., Mikami A., Vallee R.B., and Goldman R.D. A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organization. J Cell Biol. 157 (2002) 795-806
23. He Y., Francis F., Myers K.A., Black W., and Baas M.M. Role of cytoplasmic dynein in the axonal transport of microtubules and neurofilaments. J. Cell Biol. 168 (2005) 697-703
24. Hoffman P.N., Griffin J.W., Gold B.G., and Price D.L. Slowing of neurofilament transport and the radial growth of developing nerve fibers. J. Neurosci. 5 (1985) 2920-2929
25. Hurd D.D., and Saxton W.M. Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics 144 (1996) 1075-1085
26. Julien J.P. A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis. Biochem. Cell. Biol. 73 (1995) 593-597 (Review)
27. Jung C., and Shea T.B. Regulation of neurofilament axonal transport by phosphorylation in optic axons in situ. Cell Motil. Cytoskeleton 43 (1999) 230-240
28. Jung C., Yabe J., Wang F.-S., and Shea T.B. Neurofilaments are present within axonal neurites before incorporation into Triton-insoluble structures. Cell Motil. Cytoskel. 40 (1998) 44-58
29. Jung C., Yabe J.T., and Shea T.B. C-terminal phosphorylation of the heavy molecular weight neurofilament subunit is inversely correlated with neurofilament axonal transport velocity. Brain Res. 856 (2000) 12-19
30. Jung C., Yabe J.T., Lee S., and Shea T.B. Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extenisvely phosphorylated subunits in situ. Cell Motil. Cytoskeleton 47 (2000) 120-129
31. Jung C., Lee S., Ortiz D., Zhu Q., Julien J.P., and Shea T.B. The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit. Mol. Brain Res. 141 (2005) 151-155
32. Kieran D., Hafezparast M., Bohnert S., Dick J.R., Martin J., Schiavo G., Fisher E.M., and Greensmith L. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169 (2005) 561-567
33. Komiya Y., Tashiro T., and Kuokawa M. Phosphorylation of neurofilament proteins during their axonal transport. Biomed Res. 7 (1986) 345-348
34. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
35. Lasek R.J., Paggi P., and Katz M.J. Slow axonal transport mechanisms move neurofilaments relentlessly in mouse optic axons. J. Cell Biol. 117 (1992) 607-616
36. Lewis S.E., and Nixon R.A. Multiple phosphorylated variants of the high molecular mass subunit of neurofilaments in axons of retinal cell neurons: characterization and evidence for their differential association with stationary and moving neurofilaments. J. Cell Biol. 107 (1988) 2689-2701
37. Martin M., Iyadurai S.J., Gassman A., Gindhart Jr. J.G., Hays T.S., and Saxton W.M. Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport. Mol. Biol. Cell 10 (1999) 3717-3728
38. Meier J., Couillard-Despres S., Jacomy H., Gravel C., and Julien J.P. Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J. Neuropathol. Exp. Neurol. 58 (1999) 1099-1110
39. Motil J., Chan W.K.-H., Dubey M., Chaudhury P., Pimenta A., Chylinski T.M., Ortiz D.T., and Shea T.B. Dynein mediates retrograde neurofilament transport within axonal neurites and anterograde delivery of NFs from perikarya into axons: regulation by multiple phosphorylation events. Cell Motil. Cytoskeleton 63 (2006) 266-286
40. Munch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A., Prudlo J., Peraus G., Hanemann C.O., Stumm G., and Ludolph A.C. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63 (2004) 724-726
41. Nixon R.A. The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathology. Brain Pathol. 3 (1993) 29-38
42. Nixon R.A., and Logvinenko K.B. Multiple fates of newly synthesized neurofilament proteins: Evidence for a stationary neurofilament network distributed non-uniformly along axons of retinal ganglion cell neurons. J. Cell Biol. 102 (1986) 647-659
43. Rao M.V., and Nixon R.A. Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review. Neurochem. Res. 28 (2003) 1041-1047
44. Rao M.V., Garcia M.L., Miyazaki Y., Gotow T., Yuan A., Mattina S., Calcutt C.M., Uchiyama N.A., Nixon Y., and Cleveland R.A. Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport. J. Cell Biol. 158 (2002) 681-693
45. Roy S., Coffee P., Smith G., Liem R.K.H., Brady S.T., and Black M.M. Neurofilaments are transported rapidly but intermittently in axons: Implications for slow axonal transport. J. Neurosci. 20 (2000) 6849-6861
46. Sasaki S., and Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 47 (1996) 535-540
47. Sasaki S., Warita H., Abe K., and Iwata M. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 110 (2005) 48-56
48. Shah P.R., Ahmad-Annuar A., Ahmadi K.R., Russ C., Sapp P.C., Horvitz H.R., Brown Jr. R.H., Goldstein D.B., and Fisher E.M. No association of DYNC1H1 with sporadic ALS in a case-control study of a northern European derived population: a tagging SNP approach. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 7 (2006) 46-56
49. Shea T.B., Fischer I., Paskevich P.A., and Beermann M.L. The protein phosphatase inhibitor okadaic acid increases axonal NFs and neurite caliber, and decreases axonal MTs in NB2a/d1 cells. J. Neurosci. Res. 35 (1993) 507-521
50. Shea T.B., Wheeler E., and Jung C. Aluminum inhibits neurofilament assembly, cytoskeletal incoporation and axonal transport: Dynamic nature of aluminum-induced perikaryal neurofilament accumulations as revealed by subunit turnover. Mol. Chem. Neuropathol. 32 (1997) 17-39
51. Shea T.B., Jung C., and Pant H.C. Does neurofilament phosphorylation regulate axonal transport?. Trends Neurosci. 26 (2003) 397-400
52. Teuchert M., Fischer D., Schwalenstoecker B., Habisch H.J., Bockers T.M., and Ludolph A.C. A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp. Neurol. 198 (2006) 271-274
53. Theiss C., Napirei M., and Karl Meller K. Impairment of anterograde and retrograde neurofilament transport after anti-kinesin and anti-dynein antibody microinjection in chicken dorsal root ganglia. Eur. J. Cell Biol. 84 (2005) 29-43
54. Toyoshima I., Sugawara M., Kato K., Wada C., Hirota K., Hasegawa K., Kowa H., Sheetz M.P., and Masamune O. Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease. J. Neurol. Sci. 159 (1998) 38-44
55. Toyoshima I., Kato K., Sugawara M., Wada C., and Masamune O. Kinesin accumulation in chick spinal axonal swellings with beta,beta′-iminodipropionitrile (IDPN) intoxication. Neurosci. Lett. 249 (1998) 103-106
56. Veldink J.H., Van den Berg L.H., and Wokke J.H. The future of motor neuron disease: the challenge is in the genes. J. Neurol. 251 (2004) 491-500
57. Wagner O.I., Ascano J., Tokito M., Leterrier J.F., Janmey P.A., and Holzbaur E.L. The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. Mol. Biol. Cell 15 (2004) 5092-5100
58. Wang L., Ho C.-I., Sun D., Liem R.K.H., and Brown A. Rapid movements of axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol. 2 (2000) 137-141
59. Warita H., Itoyama Y., and Abe K. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 819 (1999) 120-131
60. Watson D.F., Griffin J.W., Fittro K.P., and Hoffman P.N. Phosphorylation-dependent immunoreactivity of neurofilaments increases during axonal maturation and β,β′-iminodipropionitrile intoxication. J. Neurochem. 53 (1989) 1818-1829
61. Williamson T.L., and Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2 (1999) 50-56
62. Xu Y., Takeda S., Nakata T., Noda Y., Tanaka Y., and Hirokawa N. Role of KIFC3 motor protein in Golgi positioning and integration. J. Cell Biol. 158 (2002) 293-303
63. Yabe J.T., Pimenta A., and Shea T.B. Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J. Cell Sci. 112 (1999) 3799-3814
64. Yabe J.T., Chan W., and Shea T.B. Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell Motil. Cytoskeleton 42 (2000) 230-240
65. Yabe J.T., Chylinski T., Wang F.S., Pimenta A., Kattar S.D., Linsley M.D., Chan W.K., and Shea T.B. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites. J. Neurosci. 21 (2001) 2195-2205
66. Yabe J.T., Wang F.-S., Chylinski T., Katchmar T., and Shea T.B. Selective accumulation of the high molecular weight neurofilament subunit within the distal region of growing axonal neurites. Cell Motil. Cytoskeleton 50 (2001) 1-12
67. Yuan, A., Nixon, R.A., Rao, M.V., (2005) Deleting the phosphorylated tail domain of the neurofilament heavy subunit does not alter neurofilament transport rate in vivo. Neurosci. Lett. [Electronic publication ahead of print]
68. Zhang B., Tu P., Abtahian F., Trojanowski J.Q., and Lee V.M.-Y. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139 (1997) 1307-1315